scispace - formally typeset
B

Barry R. Davis

Researcher at University of Texas at Austin

Publications -  351
Citations -  50989

Barry R. Davis is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Chlorthalidone & Amlodipine. The author has an hindex of 78, co-authored 342 publications receiving 47899 citations. Previous affiliations of Barry R. Davis include Tulane University & Cardiovascular Institute of the South.

Papers
More filters
Journal ArticleDOI

Sex-specific effects of AGT-6 and ACE I/D on pulse pressure after 6 months on antihypertensive treatment: the GenHAT study.

TL;DR: This study addresses whether two renin‐angiotensin‐aldosterone system (RAAS) variants are associated with PP in a sex‐specific manner (genotype‐by‐sex interaction) and investigates whether gender may be an effect modifier between PP and cardiovascular disease.
Journal ArticleDOI

Operational aspects of terminating randomization in the multicenter trial of cryotherapy for retinopathy of prematurity

TL;DR: The Multi-Center Trial of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) as discussed by the authors is a randomized clinical trial sponsored by the National Eye Institute (NEI) designed to test whether cryotherapy applied to eyes of premature infants with a specified extent of stage 3+ ROP significantly decreases the incidence of an unfavorable outcome.
Journal ArticleDOI

Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

TL;DR: Heterogeneity in response to antihypertensive therapies is demonstrated and chlorthalidone is associated with more favorable initial response than the other medications and provided superior discrimination for predicting downstream adverse cardiovascular events.